Qikangyuan Overview
- Year Founded
-
2021
- Status
-
Private
- Latest Deal Type
-
Joint Venture
- Financing Rounds
-
1
Qikangyuan General Information
Description
Manufacturer of medical isotopes intended for tumor diagnosis and targeted alpha therapy. The company offers germanium-68 and actinium-225 produced via medium-energy proton cyclotrons and proprietary radiochemical processes, providing a localized radionuclide supply for nuclear medicine and pharmaceutical markets to support precision oncology and diagnostic imaging.
Contact Information
Corporate Office
- Number 1668 Huacheng Road, Jintan District
- Changzhou, Jiangsu 213200
- China
Corporate Office
- Number 1668 Huacheng Road, Jintan District
- Changzhou, Jiangsu 213200
- China
Qikangyuan Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Qikangyuan Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Qikangyuan FAQs
-
When was Qikangyuan founded?
Qikangyuan was founded in 2021.
-
Where is Qikangyuan headquartered?
Qikangyuan is headquartered in Changzhou, China.
-
What industry is Qikangyuan in?
Qikangyuan’s primary industry is Pharmaceuticals.
-
Is Qikangyuan a private or public company?
Qikangyuan is a Private company.
-
What is Qikangyuan’s current revenue?
The current revenue for Qikangyuan is .
-
Who are Qikangyuan’s investors?
Eckert & Ziegler and Yantai Dongcheng Pharmaceutical Group have invested in Qikangyuan.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process